DiaMedica Therapeutics Inc (DMAC) Straddle

Trading a DMAC straddle lets you take a pure volatility position on DiaMedica Therapeutics Inc without committing to a direction. DiaMedica Therapeutics Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate DMAC straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on DMAC profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when DiaMedica Therapeutics Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the DMAC straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type I or Type II diabetes; and Phase 2/3 REMEDY2 trials for the treatment of patients with acute ischemic stroke. It is also developing DM300 that is in pre-clinical stage for the treatment of inflammatory diseases. The company was formerly known as DiaMedica Inc.

and changed its name to DiaMedica Therapeutics Inc. in December 2016. DiaMedica Therapeutics Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the DMAC straddle is the cleanest expression of that view. Our scanner prices every DMAC straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a DMAC straddle into a catalyst or short a DMAC straddle to harvest decay, the options straddle setups that matter are all in one place.